These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36075750)

  • 1. Impact of Respiratory Viral Panel Results on Piperacillin-Tazobactam Use in a Medical Intensive Care Unit: A Single-Center Retrospective Study.
    Pichlinski EM; Chong PP; Prokesch BC
    Clin Ther; 2022 Oct; 44(10):e97-e103. PubMed ID: 36075750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Acute Kidney Injury With Concomitant Vancomycin and Piperacillin/Tazobactam Treatment Among Hospitalized Children.
    Downes KJ; Cowden C; Laskin BL; Huang YS; Gong W; Bryan M; Fisher BT; Goldstein SL; Zaoutis TE
    JAMA Pediatr; 2017 Dec; 171(12):e173219. PubMed ID: 28973124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam.
    Holsen MR; Meaney CJ; Hassinger AB; Fusco NM
    Pediatr Crit Care Med; 2017 Dec; 18(12):e585-e591. PubMed ID: 28906422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes of Extended Versus Intermittent Infusion of Piperacillin/Tazobactam in Critically Ill Patients: A Prospective Clinical Trial.
    Fan SY; Shum HP; Cheng WY; Chan YH; Leung SM; Yan WW
    Pharmacotherapy; 2017 Jan; 37(1):109-119. PubMed ID: 27888542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit.
    Buckley MS; Hartsock NC; Berry AJ; Bikin DS; Richards EC; Yerondopoulos MJ; Kobic E; Wicks LM; Hammond DA
    J Crit Care; 2018 Dec; 48():32-38. PubMed ID: 30172962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute kidney injury with combination vancomycin and piperacillin-tazobactam therapy in the ICU: A retrospective cohort study.
    O'Callaghan K; Hay K; Lavana J; McNamara JF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106010. PubMed ID: 32413387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Utility of Multiplex Amplification Respiratory Viral Panel Testing in the Management of Acute Respiratory Infection in Children: A Retrospective Analysis.
    McCulloh RJ; Andrea S; Reinert S; Chapin K
    J Pediatric Infect Dis Soc; 2014 Jun; 3(2):146-53. PubMed ID: 26625367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
    Shinn K; Wetzel M; DeGroote NP; Keller F; Briones M; Felker J; Castellino S; Miller TP
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28570. PubMed ID: 32881268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Injury in Critically Ill Patients Treated with Vancomycin and Zosyn or an Alternative: A Systematic Review and Meta-Analysis.
    Blears EE; Morris J; Popp D; Lee JO; Norbury WB
    Surg Infect (Larchmt); 2022 Aug; 23(6):516-524. PubMed ID: 35736797
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study.
    Kane-Gill SL; Ostermann M; Shi J; Joyce EL; Kellum JA
    Drug Saf; 2019 Oct; 42(10):1149-1155. PubMed ID: 31240688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Retrospective Cohort of Extended-Infusion Piperacillin-Tazobactam (RECEIPT) study: a multicenter study.
    Yost RJ; Cappelletty DM;
    Pharmacotherapy; 2011 Aug; 31(8):767-75. PubMed ID: 21923603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of respiratory viral assay panel on antibiotic prescription patterns at discharge in adults admitted with mild to moderate acute exacerbation of COPD: a retrospective before- after study.
    Tickoo M; Ruthazer R; Bardia A; Doron S; Andujar-Vazquez GM; Gardiner BJ; Snydman DR; Kurz SG
    BMC Pulm Med; 2019 Jul; 19(1):118. PubMed ID: 31262278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Respiratory Viral Panel Adoption on Antibiotic Use in Ventilated Patients.
    Dinh J; Hinkle CF; Law AC; Walkey AJ; Bosch NA
    Ann Am Thorac Soc; 2023 Dec; 20(12):1777-1783. PubMed ID: 37748086
    [No Abstract]   [Full Text] [Related]  

  • 15. Vancomycin with concomitant piperacillin/tazobactam vs. cefepime or meropenem associated acute kidney injury in the critically ill: A multicenter propensity score-matched study.
    Buckley MS; Komerdelj IA; D'Alessio PA; Rangan P; Agarwal SK; Tinta NC; Martinez BK; Ziadat DS; Yerondopoulos MJ; Kobic E; Kane-Gill SL
    J Crit Care; 2022 Feb; 67():134-140. PubMed ID: 34768175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Piperacillin-Tazobactam for Antibiotic Prophylaxis in Traumatic Grade III Open Fractures.
    O'Connell CR; Kooda KJ; Sawyer MD; Wise KB; Mara KC; Skrupky LP
    Surg Infect (Larchmt); 2022 Feb; 23(1):41-46. PubMed ID: 34612703
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of respiratory viral polymerase chain reaction testing on de-escalation of antibiotic therapy in children who require chronic positive pressure ventilation.
    Beltran Ale G; Benscoter D; Hossain MM; Zhang Y; Courter J; Thomson J
    Pediatr Pulmonol; 2020 Aug; 55(8):2150-2155. PubMed ID: 32492284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities Revealed for Antimicrobial Stewardship and Clinical Practice with Implementation of a Rapid Respiratory Multiplex Assay.
    Weiss ZF; Cunha CB; Chambers AB; Carr AV; Rochat C; Raglow-Defranco M; Parente DM; Angus A; Mermel LA; Sivaprasad L; Chapin K
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31413077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinical Findings in SARS-CoV-2 with Other Respiratory Viruses in Critically Ill Children during the COVID-19 Pandemic.
    Perk O; Ozcan S; Emeksiz S; Uyar E; Gulhan B
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34865169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
    Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
    J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.